tradingkey.logo

Sonoma Pharmaceuticals Inc

SNOA
查看詳細走勢圖
3.630USD
+0.050+1.40%
收盤 12/24, 13:00美東報價延遲15分鐘
5.99M總市值
虧損本益比TTM

Sonoma Pharmaceuticals Inc

3.630
+0.050+1.40%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.40%

5天

+2.25%

1月

+13.08%

6月

+24.74%

今年開始到現在

+34.94%

1年

+32.97%

查看詳細走勢圖

TradingKey Sonoma Pharmaceuticals Inc股票評分

單位: USD 更新時間: 2025-12-24

操作建議

Sonoma Pharmaceuticals Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在藥品行業排名73/158位。機構持股佔比非常高,近一個月多位分析師給出公司評級為強力買入。最高目標價14.80。中期看,股價處於平穩狀態。近一個月,市場表現較強,基本面評分較高,但較強的走勢沒有得到技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Sonoma Pharmaceuticals Inc評分

相關信息

行業排名
73 / 158
全市場排名
181 / 4562
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 1 分析師
強力買入
評級
14.800
目標均價
+322.25%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Sonoma Pharmaceuticals Inc亮點

亮點風險
Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
業績增長期
公司處於發展階段,最新年度總收入14.29M美元
估值低估
公司最新PE估值-1.81,處於3年歷史低位
機構加倉
最新機構持股106.22K股,環比增加19.12%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉20.87K股
活躍度增加
近期活躍度增加,過去20天平均換手率-0.01

Sonoma Pharmaceuticals Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Sonoma Pharmaceuticals Inc簡介

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
公司代碼SNOA
公司Sonoma Pharmaceuticals Inc
CEOTrombly (Amy)
網址https://sonomapharma.com/

常見問題

Sonoma Pharmaceuticals Inc(SNOA)的當前股價是多少?

Sonoma Pharmaceuticals Inc(SNOA)的當前股價是 3.630。

Sonoma Pharmaceuticals Inc 的股票代碼是什麼?

Sonoma Pharmaceuticals Inc的股票代碼是SNOA。

Sonoma Pharmaceuticals Inc股票的52週最高點是多少?

Sonoma Pharmaceuticals Inc股票的52週最高點是6.920。

Sonoma Pharmaceuticals Inc股票的52週最低點是多少?

Sonoma Pharmaceuticals Inc股票的52週最低點是1.750。

Sonoma Pharmaceuticals Inc的市值是多少?

Sonoma Pharmaceuticals Inc的市值是5.99M。

Sonoma Pharmaceuticals Inc的淨利潤是多少?

Sonoma Pharmaceuticals Inc的淨利潤為-3.46M。

現在Sonoma Pharmaceuticals Inc(SNOA)的股票是買入、持有還是賣出?

根據分析師評級,Sonoma Pharmaceuticals Inc(SNOA)的總體評級為--,目標價格為14.800。

Sonoma Pharmaceuticals Inc(SNOA)股票的每股收益(EPS TTM)是多少

Sonoma Pharmaceuticals Inc(SNOA)股票的每股收益(EPS TTM)是-2.007。
KeyAI